LTRAs urged for poorly controlled asthma


  • The BMJ
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

A leucotriene receptor antagonist should be offered before a combination inhaler in patients with poorly controlled asthma, draft guidance from the National Institute for Health and Care Excellence (NICE) recommends.1

The generic leucotriene receptor antagonist montelukast costs just 7p (€0.08; $...